Portland, OR -- (SBWIRE) -- 07/27/2017 -- Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few DNA strands. This technology allows the rapid sequencing of millions of base pairs of DNA spanning entire genomes. The launch of new generation sequencers has opened up various markets, especially in the field of research, diagnostics and personalized medicine. The major drivers for this market are the need for constant developments with the aim of achieving an increased accuracy at a lower cost. The increasing applications for this technology, its potential as a replacement for microarray technology, decreasing costs and faster turnaround time are other factors driving this market. However, a decrease in expenditure by academic institutes, dependency of researchers on grants, issues with accuracy, standardization and interpretation of complex data are the impediments to the growth of this market.

Get full summary of the Report:https://www.alliedmarketresearch.com/next-generation-sequencers-market

Some of the the key players in this market are Illumina, Life Technologies, Roche, Applied Biosystems, Pacific Biosciences, Complete Genomics, Oxford Nanopore Technologies and others. In 2013, The UAB Research Foundation licensed its nanopore technology to Illumina, a giant in the Next Generation Sequencing Market. Nanopore technology is the latest technological development in Next Generation Sequencing. With this deal, Illumina would add to its existing technologies and maintain a competitive edge in the market.
The report describes the segments of next generation sequencers market. Porters five force model helps in analyzing the bargaining power of suppliers and buyers, as well as the threat posed by new entrants. Market is analyzed by the strategic moves made by competitors, which will enable stakeholders to make decisions. Investments and partnerships, especially with researchers coming up with new technologies would enable companies to stay ahead in this competitive market.

Get sample of the Report:https://www.alliedmarketresearch.com/request-toc-and-sample/263

KEY DELIVERABLES

The next generation Sequencers market is segmented by technology, application, requirements for processing, end users and geography.

Next Generation Sequencers Market by Technology

-Sequencing by synthesis
-Ion semiconductor sequencing
-Sequencing by ligation
-Pyrosequencing
-Single molecule, real-time (SMRT) Sequencing
-Nanopore Sequencing
-Others

Next Generation Sequencers Market-by Application

-Drug Discovery
-Biomarker Discovery
-Diagnostics
-Agriculture and Animal Research
-Metagenomics
-Personalized Medicine
-Others

Next Generation Sequencers Market by Requirements for Processing

-Pre-sequencing Products and Services
-Sequencing Instruments Platforms
-Consumables/Reagents
-NGS software and informatics

Next Generation Sequencers Market by End Users

-Research Institutes
-Academic and Government Institutions
-Hospitals & Clinics
-Pharmaceutical and biotechnology Companies
-Others

Next Generation Sequencers Market by Geography

-North America
-Europe
-Asia-Pacific
-RoW